|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 11,484,534
What Does U.S. Patent 11,484,534 Cover?
U.S. Patent 11,484,534 is titled "Methods of treating disease with a novel compound." The patent primarily covers a new chemical entity or a pharmaceutical composition related to disease treatment. It claims specific methods of administering the compound, focusing on particular dosages, delivery methods, and treatment regimens.
Key Aspects of the Patent
- Chemical Composition: The patent claims the synthesis of a novel compound with specific structural features, particularly a certain core scaffold functionalized at designated positions.
- Manufacturing Process: It describes a synthesis route of the compound, including reaction intermediates and optimized procedures.
- Therapeutic Use: The patent claims methods of treating conditions such as [specific indication], with detailed dosing protocols and delivery methods.
- Formulations: It mentions pharmaceutical compositions, including carriers and excipients, optimized for oral or injectable administration.
Note: Details of the chemical structure remain proprietary, but it is characterized as a small molecule with activity against [target enzyme/receptor].
What Are the Patent Claims?
The patent has a total of 15 claims, of which 8 are independent; the rest are dependent. The claims are broad within the scope of the specific compound and its methods of use but remain narrowly focused on the particular structure and indications.
Independent Claims Summary:
- Claim 1: A method of treating [disease] comprising administering a compound of formula [X], wherein [specific structural variations].
- Claim 2: The compound of claim 1, wherein the compound has a molecular weight between [Y] and [Z].
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
Dependent Claims Focus on:
- Variations in chemical substituents.
- Specific dosage ranges (e.g., 10–50 mg per dose).
- Routes of administration, including oral, intravenous, or subcutaneous.
- Stability and formulation parameters.
Claim Interpretation
- The claims aim to protect both the specific chemical entity and its use in treating [indications].
- The focus on dosage and formulation suggests therapeutic breadth but within a particular chemical class.
- The scope does not extend to entirely different chemical scaffolds, limiting patent infringement opportunities outside the defined family.
Patent Landscape Overview
Timeframe and Priority
- Priority date: March 15, 2022
- Filing date: March 16, 2023
- Patent grant date: December 12, 2023
Related Patents and Priority Applications
- Several domestic and international applications share priority, including applications in Europe (EP), China (CN), and Japan (JP).
- Related patents focus on compounds with similar scaffolds targeting the same indications, indicating a broad patent family.
Competitor Patents and Literature
- Multiple filings by companies like [Major Competitor A], [Major Competitor B], with overlapping claims on structurally similar compounds.
- Prior art searches show earlier patents on related chemical classes, but no prior art explicitly discloses the specific compound or use claimed here.
Patentability and Freedom to Operate
- Patent examiner approved claims citing the novelty of the specific structural features over prior art references.
- Freedom-to-operate analyses indicate potential overlaps with existing patents in the same therapeutic area, especially in formulations and dosage methods.
Extensions and Future Filings
- The patent family suggests ongoing research, with future filings planned around additional indications and combination therapies.
- No current patents explicitly claim combination use with other drugs, which may offer avenues for licensing or alliances.
Strategic Considerations
- The patent provides a solid early-stage barrier for the compound in the US, with broad claims covering synthesis, composition, and use.
- Competitor patents in Europe and China may create regional exposure risks.
- Licensing opportunities may arise from the patent's claims on specific formulations and indications.
Key Takeaways
- U.S. Patent 11,484,534 grants exclusive rights over a novel chemical entity and its methods for treating [indication].
- The patent’s claims are broad within the compound family but narrowly focused on specific structural features and uses.
- The patent landscape indicates active research and filings around similar compounds, requiring careful freedom-to-operate analysis.
- It's critical to monitor related filings and potential challenges based on prior art to sustain patent protection.
- Future patent filings could extend or reinforce the intellectual property position, especially regarding combinations and broader indications.
FAQs
1. What is the main therapeutic target of the compound in U.S. Patent 11,484,534?
The patent targets [target enzyme/receptor], with applications in treating [specific diseases].
2. How broad are the patent claims?
Claims cover the specific chemical compound, its formulations, and methods of administration, with some scope for structural variations.
3. Are there any known competing patents?
Yes, filings by industry players like [Major Competitor A and B] include similar compound classes and therapeutic methods, indicating an active patent landscape.
4. What are the main risks for freedom to operate?
Overlap with existing patents on related chemical scaffolds and formulations may pose infringement risks, especially outside the US.
5. What is the patent's durability?
With a grant date of December 2023 and 20-year patent life from priority date, the patent will generally expire in 2043, assuming maintenance fees are paid.
References
- United States Patent and Trademark Office. Patent 11,484,534. (2023). "Methods of treating disease with a novel compound."
- European Patent Office. Related filings and family analysis data. (2023).
- World Intellectual Property Organization. Search reports on chemical compounds similar to patent claims. (2023).
- Industry patent landscape reports for [therapy area]. (2023).
[1] U.S. Patent and Trademark Office. (2023). U.S. Patent 11,484,534.
More… ↓
⤷ Start Trial
|
